Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Clinical trial NCT02470091 · COMPLETED

Trial details

NCT number: NCT02470091
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Osteosarcoma Recurrent Osteosarcoma Refractory Osteosarcoma Stage IV Osteosarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7

Start date: 2015-11-21
Primary completion: 2019-12-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.